Recruiting studies: Symptomatic Congestive Heart Failure

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Study With Omecamtiv Mecarbil (CK-1827452) to Treat Chronic Heart Failure With Severely Reduced Ejection Fraction
Phase 3 · 196 location(s) · Cytokinetics · NCT06736574 A Study to Evaluate Finerenone on Clinical Efficacy and Safety in Patients With Heart Failure Who Are Intolerant or Not
Phase 3 · 176 location(s) · Colorado Prevention Center · NCT06033950 Use of Bedside Imaging and Community Health Workers for Early Screening and Referral of Pre-symptomatic Stage B Heart Fa
NA · 1 location(s) · Rush University Medical Center · NCT06769880 Evaluation of the Impact of Interventional Treatments for Symptomatic, Severe Tricuspid Valve Insufficiency on Renal Int
Phase N/A · 1 location(s) · Robert Bosch Medical Center · NCT07464106 Multi-center Trial of Ferric Derisomaltose Versus no Intravenous Iron in Iron-deficient Subjects With Symptomatic Chroni
Phase 3 · 1 location(s) · Pharmacosmos A/S · NCT06929806 Reduction of Mitral Regurgitation With the SATURN Trans-Septal Transcatheter Mitral Valve Replacement (TMVR) System in P
NA · 8 location(s) · InnovHeart · NCT06414265 A Study to Test Whether Vicadrostat (BI 690517) in Combination With Empagliflozin Helps People With Heart Failure and a
Phase 3 · 632 location(s) · Boehringer Ingelheim · NCT06935370 Assessment of CCM in HF With Higher Ejection Fraction
NA · 105 location(s) · Impulse Dynamics · NCT05064709 The Predictive Value of Dobutamine Echo-stress in the Clinical Response to CCM Therapy in Advanced HF
Phase N/A · 13 location(s) · Quovadis Associazione · NCT06973902 A Study Of CS Reducer For Symptomatic Heart Failure With HFpEF And CMD
Phase N/A · 1 location(s) · Mayo Clinic · NCT07093528 A Prospective Registry Study to Assess Real-world Patient Characteristics, Treatment Patterns, and Longitudinal Outcomes
Phase N/A · 99 location(s) · Bristol-Myers Squibb · NCT05489705 Study to Assess Safety and Efficacy of Treating Symptomatic, Ischemic, Chronic Congestive Heart Failure Patients with an
Phase 2 · 1 location(s) · Ralf Rothoerl · NCT06705023 A Study to Test Whether Vicadrostat in Combination With Empagliflozin Helps People With Heart Failure
Phase 3 · 652 location(s) · Boehringer Ingelheim · NCT06424288 AMBER-HFpEF: Assessment of CK-4021586 in a Multi-Center, Blinded Evaluation of Safety and Tolerability Results in HFpEF
Phase 2 · 25 location(s) · Cytokinetics · NCT06793371 HARMONY Trial : To Evaluate a Therapeutic and Monitoring Device(NOVAtria System) for Heart Failure Management
NA · 15 location(s) · United Innomed(Shanghai) Limited · NCT07402239 Synchronized Diaphragmatic Stimulation in Symptomatic Heart Failure
NA · 1 location(s) · VisCardia Inc. · NCT06552637 Ablate and Pace HIS Study
NA · 1 location(s) · University Hospitals, Leicester · NCT06152406

Look up another condition

Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.